Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record
- 1 February 2021
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 61 (2), 181-186
- https://doi.org/10.1002/jcph.1717
Abstract
Adverse drug reactions (ADRs) often go unreported or are inaccurately documented in the electronic medical recorded (EMR), even when they are severe and life-threatening. Incomplete reporting can lead to future prescribing challenges and ADR reoccurrence. The aim of this study was to evaluate the documentation of ADRs within the EMR and determine specific factors associated with appropriate and timely ADR documentation. Retrospective data were collected from a pediatric hospital system ADR reports from October 2010 to November 2018. Data included implicated medication, type, and severity of reaction, treatment location, the presence or absence of ADR documentation in the EMR alert profile within 24 hours of the ADR hospital or clinic encounter discharge, ADR identification method, and the presence or absence of pharmacovigilance oversight at the facility where the ADR was treated. A linear regression model was applied to identify factors contributing to optimal ADR documentation. A total of 3065 ADRs requiring medical care were identified. Of these, 961 ADRs (31%) did not have appropriate documentation added to the EMR alert profile prior to discharge. ADRs were documented in the EMR 87% of the time with the presence of pharmacovigilance oversight and only 61% without prospective pharmacovigilance (P< .01). Severity of ADR was not a predictor of ADR documentation in the EMR, yet the implicated medication and location of treatment did impact reporting. An active pharmacovigilance service significantly improved pediatric ADR documentation. Further work is needed to assure timely, accurate ADR documentation.Keywords
This publication has 22 references indexed in Scilit:
- Characterization of Severe Adverse Drug Reactions at a Free‐Standing Children's HospitalThe Journal of Clinical Pharmacology, 2019
- Moving to a World Beyond “p < 0.05”The American Statistician, 2019
- Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting ratesJournal of Drug Assessment, 2019
- Study on the Classification, Causality, Preventability and Severity of Adverse Drug Reaction Using Spontaneous Reporting System in Hospitalized PatientsPharmacy, 2018
- Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency DepartmentJournal of Medical Toxicology, 2018
- Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart HospitalDrugs & Aging, 2017
- Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labelsInternal Medicine Journal, 2017
- Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods DesignJMIR Research Protocols, 2016
- Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children’s HospitalTherapeutic Innovation & Regulatory Science, 2013
- Adverse Drug Reactions Among Children Over a 10-Year PeriodPediatrics, 2006